by Anne Halliwell
In mid-March, Mayo Clinic in Rochester was the first medical institution to begin performing endoscopic lung volume reductions. The procedure was approved by the FDA for clinical use in 2018. Only a few medical centers nationwide offer the treatment for chronic obstructive pulmonary disease (COPD), which alleviates some symptoms of advanced emphysema.
Reach: The Rochester Post-Bulletin is a daily newspaper that serves Rochester, Austin and its surrounding cities. The newspaper has a daily circulation of more than 30,000 and a weekend circulation of more than 36,000. The Post-Bulletin online has more than 440,000 unique visitors to its website each month.
Context: This procedure, which recently was approved by the Food and Drug Administration (FDA), treats patients experiencing disorders associated with chronic obstructive pulmonary disease (COPD), including advanced emphysema and chronic bronchitis. Only a few medical centers nationwide offer this treatment. You can read more about the procedure on Mayo Clinic News Network.